Disease
6 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
This is an active registry record for an observational feasibility study of a novel tau-PET tracer with no results yet posted; it describes planned safety and biodistribution assessment in 20 participants.
This is a completed Phase 2 pilot study with very small enrollment (n=5) assessing only safety and tolerability of fisetin; no efficacy results are reported in this registry record.
AUG 13, 2026 · PHASE 1 TRIAL
ClinicalTrials.gov
This is a Phase 1, open-label dose escalation study in early recruitment that has not yet posted results; it represents first-in-human work designed to characterize safety and tolerability.
AUG 10, 2026 · INTERVENTIONAL STUDY
ClinicalTrials.gov
This is a completed trial registration with no posted results; the study design is sound (RCT, n=24) but outcome data are not yet reported, making it a prospective record of a small pilot-stage intervention.
JUL 31, 2026 · INTERVENTIONAL STUDY
ClinicalTrials.gov
This is an active registry record describing a planned interventional study with no results posted; evidence quality cannot be assessed until completion and outcome reporting.
JUL 31, 2026 · PHASE 1 TRIAL
ClinicalTrials.gov
This is a Phase 1 registry record for a planned interventional study with no results posted; it describes study design and enrollment targets only.